These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23642183)

  • 1. Natural polyphenols in the management of major depression.
    Pathak L; Agrawal Y; Dhir A
    Expert Opin Investig Drugs; 2013 Jul; 22(7):863-80. PubMed ID: 23642183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review.
    Nabavi SM; Daglia M; Braidy N; Nabavi SF
    Nutr Neurosci; 2017 Apr; 20(3):180-194. PubMed ID: 26613119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress.
    Liu Y; Jia G; Gou L; Sun L; Fu X; Lan N; Li S; Yin X
    Pharmacol Biochem Behav; 2013 Mar; 104():27-32. PubMed ID: 23290936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical discovery of duloxetine for the treatment of depression.
    Torres-Sanchez S; Perez-Caballero L; Mico JA; Elorza J; Berrocoso E
    Expert Opin Drug Discov; 2012 Aug; 7(8):745-55. PubMed ID: 22680253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-depressive effect of polyphenols and omega-3 fatty acid from pomegranate peel and flax seed in mice exposed to chronic mild stress.
    Naveen S; Siddalingaswamy M; Singsit D; Khanum F
    Psychiatry Clin Neurosci; 2013 Nov; 67(7):501-8. PubMed ID: 24152226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
    Lopresti AL; Hood SD; Drummond PD
    J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?
    Fornaro M; Aguglia E; Dell'Osso L; Perugi G
    Expert Opin Pharmacother; 2011 Dec; 12(18):2817-31. PubMed ID: 22098226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to the pharmacological management of major depressive disorder.
    Witkin JM; Li X
    Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.
    Prins J; Olivier B; Korte SM
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1107-30. PubMed ID: 21682663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy.
    Rajagopal C; Lankadasari MB; Aranjani JM; Harikumar KB
    Pharmacol Res; 2018 Apr; 130():273-291. PubMed ID: 29305909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preventive and therapeutic potential of natural polyphenols on influenza.
    Bahramsoltani R; Sodagari HR; Farzaei MH; Abdolghaffari AH; Gooshe M; Rezaei N
    Expert Rev Anti Infect Ther; 2016; 14(1):57-80. PubMed ID: 26567957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoencapsulation of Polyphenols as Drugs and Supplements for Enhancing Therapeutic Profile - A Review.
    Khatoon S; Kalam N; Shaikh MF; Hasnain MS; Hafiz AK; Ansari MT
    Curr Mol Pharmacol; 2022; 15(1):77-107. PubMed ID: 34551693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on glutamate receptor antagonists as antidepressants.
    Chung C
    Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutamatergic neurotransmission, depression and antidepressants].
    Ferrero A; Cereseto M
    Vertex; 2004; 15(56):91-8. PubMed ID: 15243652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin releasing factor receptor antagonists for major depressive disorder.
    Paez-Pereda M; Hausch F; Holsboer F
    Expert Opin Investig Drugs; 2011 Apr; 20(4):519-35. PubMed ID: 21395482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test.
    Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():12-7. PubMed ID: 22960607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.